Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Other Net Income (Loss) : ¥-0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Other Net Income (Loss)?

Wanbangde Pharmaceutical Holding Group Co's Other Net Income (Loss) for the three months ended in Mar. 2024 was ¥-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0 Mil.

Wanbangde Pharmaceutical Holding Group Co's quarterly Other Net Income (Loss) declined from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥-0 Mil) but then increased from Dec. 2023 (¥-0 Mil) to Mar. 2024 (¥-0 Mil).

Wanbangde Pharmaceutical Holding Group Co's annual Other Net Income (Loss) declined from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥0 Mil) and declined from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥0 Mil).

Wanbangde Pharmaceutical Holding Group Co Other Net Income (Loss) Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Other Net Income (Loss) Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Wanbangde Pharmaceutical Holding Group Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

Wanbangde Pharmaceutical Holding Group Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008

Website

http://www.wepon.com.cn

Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.

Executives

Zhao Shou Ming	Directors, executives
Wang Tian Fang	Director
Li Rong Fang	Supervisors
Zhu Jian Xin	Directors, executives
Yang Jin Rong	Executives
Song Tie He	Directors, executives
Song Jian Hua	Executives
Pan Yun Chu	Director
Yu Ju Ming	Executives
Yang Mei Gen	Executives
Tao Jian Feng	Supervisors
Qian Shu Sheng	Executives
Shen Bai Ming	Director
Xu Yin Sheng	Director
Shuang Zhi Wei	Executives

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Headlines

No Headlines